Open Access 01.12.2017 | Correction
Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
Erschienen in: Cardiovascular Diabetology | Ausgabe 1/2017